1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Main population, neonatal, and delivery characteristics (n = 26)^{^a}
Characteristics 
Pregnancy and maternal 
    Maternal age (yr) 32.5 (21–42)
    In vitro fertilization 3/26 (11.5%)
    Multiple pregnancies 2/26 (7.7%)
    Maternal infection 5/26 (19.2%)
        CMV 4/26 (15.3%)
        Toxoplasma 1/26 (3.8%)
    Maternal medical treatment 5/26 (19.2%)
    Maternal hypercoagulative disorder 4/26 (15.3%)
    TOP 6/26 (23.1%)
Fetal and neonatal 
    Male/female ratio (15:11) 1.4:1
    Fetal abnormalities 
        IUGR 4/26 (15.4%)
        CMV infection 2/26 (7.7%)
        Chromosomal aberration 2/26 (7.7%)
        Abnormal fetal echocardiogram findings 1/26 (3.8%)
    GA at MRI diagnosis (wk) 33 (29–38)
    Birth GA (wk) 38 (35–41)
    BW (g) 3210 (2445–4060)
    Apgar score 
        At 1 min 9 (8–9)
        At 5 min 10 (8–10)
Mode of delivery (n = 20) 
    Vaginal delivery 11/20 (55%)
    Cesarean delivery 7/20 (35%)
    Assisted vaginal delivery 2/20 (10%)
Note:—GA indicates gestational age, BW, birth weight.
↵a Data are expressed as median (range) or number (percentage).